ARTICLE | Clinical News
LiquiVent: To begin Phase I trials shortly
August 2, 1993 7:00 AM UTC
Alliance Pharmaceuticals Inc. (ALLP) Product: LiquiVent, liquid perfluorochemical Indication: Respiratory Distress Syndrome in infants who have failed conventional therapy Status: To begin Phase I tri...